Chemotherapy is the treatment modality that employs drugs to kill cancer cells. The drugs enter the bloodstream and travel through the body in order to kill cancer cells. The side effects of chemotherapy come from the fact that the drugs destroy normal cells, as well.
Chemotherapy for testicular cancer usually involves some combination of bleomycin, etoposide, cisplatin, ifosfamide, and carboplatin. For some tumors, very high-dose chemotherapy (sufficient to eradicate bone marrow cells) is given, followed by stem cell transplant.
Chemotherapy is usually given by vein, but some forms can be given by mouth as well. Your oncologist will tell you how many cycles or courses of chemotherapy are best for you. Usually there are between 3-4 cycles of chemotherapy given when the chemotherapy is the only form of treatment.
The side effects and amount of time required in the doctor’s office depend on the type of chemotherapy you receive, as well as how many cycles you receive and how often. The most common chemotherapy-associated side effects are:
Most of these side effects are temporary, though some may be permanent. Discuss the implications of chemotherapy side effects with your oncologist.
Chemotherapy is given primarily after surgery in the treatment of nonseminomas. Sometimes it is also given if a seminoma is very large or it has spread to the lung, brain, or other organs.
American Cancer Society website. Available at: http://www.cancer.org. Accessed January 31, 2006.
Chemotherapy for testicular cancer. American Cancer Society website. Available at: http://www.cancer.org/cancer/testicularcancer/detailedguide/testicular-cancer-treating-chemotherapy. Updated February 13, 2015. Accessed September 29, 2015.
Drugs approved for testicular cancer. National Cancer Institute website. Available at: http://www.cancer.gov/about-cancer/treatment/drugs/testicular. Updated October 8, 2014. Accessed September 29, 2015.
Testicular cancer. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated May 31, 2012. Accessed September 29, 2015.
8/11/2011 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Oliver RT, Mead GM, Rustin GJ, et al. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol. 2011;29(8):957-962.
Last reviewed September 2015 by Mohei Abouzied, MD, FACP
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2012 EBSCO Publishing All rights reserved.
What can we help you find?close ×